NCT01417702

Brief Summary

Inflammatory bowel disease (IBD) encompasses two major forms of chronic intestinal disorders, Crohn's disease and ulcerative colitis (UC). Diagnosis is based on several macroscopic and histologic features including patterns of inflammation, crypt abscesses and granulomas. i-Scan use an endoscopic image from the video processor and reconstruct virtual images in real time, resulting in an improved contrast of the capillary patterns and enhancement of the mucosal surface (so called virtual chromoendoscopy). The main objective of this study is to determine endoscopic features of mucosal healing in patients with IBD and to compare these features to clinical and histological data in order to establish a new endoscopic classification of mucosal healing and to evaluate mucosal healing as a parameter of remission and relapse.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
232

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

August 10, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 16, 2011

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
Last Updated

December 14, 2020

Status Verified

December 1, 2020

Enrollment Period

2.8 years

First QC Date

August 10, 2011

Last Update Submit

December 10, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mucosal healing

    We will determine high-definition white light endoscopic and i-Scan features of mucosal inflammation (e.g. erosions, erythema, ulcerous lesions) in IBD in order to establish a new endoscopic classification of mucosal healing.

    up to three years

Secondary Outcomes (2)

  • Histologic correlation

    up to three years

  • Therapeutic effect

    up to three years

Study Arms (4)

Crohn´s disease - active

Patients in the active phase of the disease

Device: High-definition white light endoscopy and i-Scan

Crohn´s disease - quiescent

Patients in the quiescent phase of the disease

Device: High-definition white light endoscopy and i-Scan

Ulcerative colitis - active

Patients in the active phase of the disease

Device: High-definition white light endoscopy and i-Scan

Ucerative colitis - quiescent

Patients in the quiescent phase of the disease

Device: High-definition white light endoscopy and i-Scan

Interventions

Patients will undergo advanced endoscopic imaging. Findings will be compared to histopathological and clinical results.

Crohn´s disease - activeCrohn´s disease - quiescentUcerative colitis - quiescentUlcerative colitis - active

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with Crohn´s disease and ulcerative colitis were prospectively included.

You may qualify if:

  • Written informed consent
  • Age 18-85 years
  • Ability of subjects to understand character and individual consequences of clinical trial
  • Subjects undergoing colonoscopy

You may not qualify if:

  • Inability to provide written informed consent
  • Severe Coagulopathy (Prothrombin time \< 50% of control, Partial thromboplastin time \> 50 s)
  • Pregnancy or breast feeding
  • Active gastrointestinal bleeding
  • Residing in institutions (e.g. prison)
  • Proctocolectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Erlangen-Nuremberg

Erlangen, 91054, Germany

Location

MeSH Terms

Conditions

Crohn DiseaseColitis, Ulcerative

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesColitisColonic Diseases

Study Officials

  • Helmut Neumann, Professor

    Department of Medicine I, University of Erlangen-Nuremberg, Germany

    PRINCIPAL INVESTIGATOR
  • Markus F. Neurath, Professor

    Department of Medicine I, University of Erlangen-Nuremberg, Germany

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 10, 2011

First Posted

August 16, 2011

Study Start

August 1, 2011

Primary Completion

May 1, 2014

Study Completion

November 1, 2014

Last Updated

December 14, 2020

Record last verified: 2020-12

Locations